MedTrace Logo

Prospective rAndomized sTudy efficaCy tHree-dimensional rEconstructions Segmentectomy

NCT05716815 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2023-08-29

No results posted yet for this study

Summary

With this project we want to study the effectiveness of 3D reconstruction of preoperative CT to reduce operating times, blood loss and conversions after segmentectomy performed in thoracoscopy / robotics.

Conditions

Interventions

DIAGNOSTIC_TEST

CT scans 2D Reconstruction

Before performing the surgery, patient performs a chest CT scan with contrast medium and standard two-dimensional (2D) reconstructions are performed to study the lesion, the anatomy of the bronchi and the pulmonary venous and arterial vessels.

DIAGNOSTIC_TEST

CT scans 2D plus 3D Reconstruction

Before performing the surgery, patient performs a chest CT scan with contrast medium and standard two-dimensional (2D) reconstructions plus a 3D reconstruction are performed to study the lesion, the anatomy of the bronchi and the pulmonary venous and arterial vessels.

Sponsors & Collaborators

  • European Institute of Oncology

    collaborator OTHER

  • Philipps University Marburg

    collaborator OTHER

  • Ernst von Bergmann Hospital

    collaborator OTHER

  • Chinese University of Hong Kong

    collaborator OTHER

  • Wolfson Medical Center

    collaborator OTHER_GOV

  • University of Belgrade

    collaborator OTHER

  • Harvard University

    collaborator OTHER

  • University of Salamanca

    collaborator OTHER

  • Ospedale Centrale Bolzano

    lead OTHER

Principal Investigators

  • ZARACA FRANCESCO · Central Hospital Bolzano

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2026-03-01
Completion
2026-05-01

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05716815 on ClinicalTrials.gov